Pharmacopeia
Master Compare
Compare candidate-facing canonical Pharmacopeia fields side by side. Isolated AI-draft proposals are never included.
| Field |
DIGOXIN ANTIBODIES
Antidotes · Antidotes · Level 3
|
Intralipid 20%
Antidotes · Antidotes · Level 3
|
|---|---|---|
| Mechanism of action | Binds excess digoxin or digitoxin molecules circulating in the blood |
- unclear |
| Physiological effects | — | - energy substrate (essential fatty acids) |
| Absorption | - |
IV only |
| Protein binding | - |
None |
| Volume of distribution | 0.3 L/kg [DigiFab] |
Wide - distributed to fat and tissues |
| Metabolism | Nil |
Liver |
| Excretion | Urine |
Liver and kidneys |
| Half-life | Unbound: 11 hrs |
not well defined |
| Adverse Effects Toxicity | Anaphylaxis – rare |
- Fat embolism |
| Chemical Pharmaceutics | Monoclonal antibody (mAB) FAB (Fragment antigen-binding) fragment from sheep immunized with digoxin derivative |
fat emulsion |
| Class Group | Antidote |
Antidote Antidotes · Antidotes Antidotes |
| Indications Uses | - For treatment of acute and chronic digoxin overdose |
- TPN mixtures |
| Legacy Cicm Level | Level 3 |
Level 3 |
| Main Action | Binds Digoxin Molecules |
- Energy substrate |
| Onset Peak Duration | Onset: 0-60min |
(For LA tox) |
| Presentation | powder |
white, oil-water emulsion with 20% soybean oil, egg yolk phospholipids, glycerin, sodium hydroxide and water |
| Route And Dose | IV Empiric: 10vials of Fab fragments Known dose, no level: Known concentration: |
IV For LA tox: 1.5ml/kg bolus over 1 minute → If not stabilized, two subsequent boluses may be given 5 mins apark. Max cumulative dose 12ml/kg |
| Special Points | — | serum amylase or lipase should be monitored for |